4005 住友化学

時価

6380億円

PER 予

25.21倍

2010年以降

赤字-137.94倍
（2010-2024年）

0.69倍

2010年以降

0.46-1.77倍
（2010-2024年）

2.34%

ROE 予

2.75%

ROA 予

0.67%

Net Changes Of Items Other Than Shareholders EquityFTA、Share Of Profit Loss Of Investments Accounted For Using Equity MethodIFRS - Information Electronic Chemistry Reportable Segment Member、Non Current LabilitiesIFRS他2件

【期間】

年度	Net Changes Of Items Other Than Shareholders EquityFTA		Share Of Profit Loss Of Investments Accounted For Using Equity MethodIFRS - Information Electronic Chemistry Reportable Segment Member		Non Current LabilitiesIFRS		外部収益 - 健康・農業関連事業		Other Capital Surplus
2018/09	-		-		-		1381億		-
2019/09	-		-		-		1463億	+5.9%	-
2020/09	-		-		-		1861億	+27.2%	-
2021/09	-		-		-		2094億	+12.6%	-
2022/09	-		-		-		2939億	+40.3%	-
2023/09	-		-		-		2412億	-17.9%	-
2024/09	-		-		-		2384億	-1.2%	-

2018年9月

Net Changes Of Items Other Than Shareholders EquityFTA: -
Share Of Profit Loss Of Investments Accounted For Using Equity MethodIFRS - Information Electronic Chemistry Reportable Segment Member: -
Non Current LabilitiesIFRS: -
外部収益 - 健康・農業関連事業: 1381億3900万
Other Capital Surplus: -

2019年9月

Net Changes Of Items Other Than Shareholders EquityFTA: -
Share Of Profit Loss Of Investments Accounted For Using Equity MethodIFRS - Information Electronic Chemistry Reportable Segment Member: -
Non Current LabilitiesIFRS: -
外部収益 - 健康・農業関連事業: 1463億1100万
Other Capital Surplus: -

2020年9月

Net Changes Of Items Other Than Shareholders EquityFTA: -
Share Of Profit Loss Of Investments Accounted For Using Equity MethodIFRS - Information Electronic Chemistry Reportable Segment Member: -
Non Current LabilitiesIFRS: -
外部収益 - 健康・農業関連事業: 1860億5000万
Other Capital Surplus: -

2021年9月

Net Changes Of Items Other Than Shareholders EquityFTA: -
Share Of Profit Loss Of Investments Accounted For Using Equity MethodIFRS - Information Electronic Chemistry Reportable Segment Member: -
Non Current LabilitiesIFRS: -
外部収益 - 健康・農業関連事業: 2094億2700万
Other Capital Surplus: -

2022年9月

Net Changes Of Items Other Than Shareholders EquityFTA: -
Share Of Profit Loss Of Investments Accounted For Using Equity MethodIFRS - Information Electronic Chemistry Reportable Segment Member: -
Non Current LabilitiesIFRS: -
外部収益 - 健康・農業関連事業: 2939億200万
Other Capital Surplus: -

2023年9月

Net Changes Of Items Other Than Shareholders EquityFTA: -
Share Of Profit Loss Of Investments Accounted For Using Equity MethodIFRS - Information Electronic Chemistry Reportable Segment Member: -
Non Current LabilitiesIFRS: -
外部収益 - 健康・農業関連事業: 2412億2300万
Other Capital Surplus: -

2024年9月

Net Changes Of Items Other Than Shareholders EquityFTA: -
Share Of Profit Loss Of Investments Accounted For Using Equity MethodIFRS - Information Electronic Chemistry Reportable Segment Member: -
Non Current LabilitiesIFRS: -
外部収益 - 健康・農業関連事業: 2384億3100万
Other Capital Surplus: -